 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forum Programme
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| INTRODUCTION | ||
8:50 a.m. |
Dr Richard Horton Editor-in-Chief and Publisher, The Lancet, UK Mr Khaw Boon Wan Minister for Health, Singapore |
|
| OPENING SESSION | ||
Moderator Dr Richard Horton Editor-in-Chief and Publisher, The Lancet, UK |
||
| 9:10 a.m. | Keynote Lecture 1 Cancer incidence: an Asian perspective Dr D Max Parkin Clinical Trials Service Unit & Epidemiological Studies Unit, University of Oxford, Oxford, UK |
|
| 9:40 a.m. | Asian cancer aetiology and prevention Prof Kazuo Tajima Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan |
|
| 10:00 a.m. | Clinical research in Asia: the importance of collaboration and the role of IARC and the WHO Mr Jacques Ferlay International Agency for Research on Cancer, Lyon, France |
|
| 10:20 a.m. | World Cancer Declaration and compliance in Asia: role of the UICC |
|
| 10:40 a.m. | Role of multidisciplinary care and regional centres of excellence Prof Soo Khee Chee National Cancer Centre of Singapore, Singapore |
|
| 11:00 a.m. | Delivery of quality cancer care in countries with limited infrastructure Prof Ketayun Dinshaw Department of Radiation Oncology, Tata Memorial Hospital, Mumbai, India |
|
| 11:20 a.m. | TEA BREAK | |
| PREVENTION AND DIAGNOSIS I | ||
Moderator Prof Jatin P Shah Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA |
||
| 11:50 a.m. | H pylori, COX-2 inhibitors, and prevention of gastric cancer |
|
| 12:10 p.m. | Prevention and surveillance of hepatitis-B-related hepatocellular carcinoma |
|
| 12:30 p.m. | 15 years of follow-up: what have we learned from the oesophageal Nutrition Intervention Trials in Linxian, China? Prof You-Lin Qiao Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, Beijing, China |
|
| 12:50 p.m. | Oral cancers – Asian Perspective Prof Anil D’Cruz Head and Neck Services, Tata Memorial Hospital, Mumbai, India |
|
| 1:10 p.m. | Current developments in prevention strategies and diagnostics in colorectal cancer Prof Toshiaki Watanabe Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan |
|
| 1:35 p.m. | LUNCH AND POSTER SESSION I | |
| DISEASE MANAGEMENT I | ||
Moderator Prof Joseph J Sung Institute of Digestive Diseases, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong |
||
| 2:35 p.m. | Management of stomach cancer |
|
| 2:55 p.m. |
Current management strategies for liver cancer Prof Morito Monden Department of Surgery, Osaka University, Osaka, Japan |
|
| 3:15 p.m. | Oesophageal cancer, East and West: same name, different disease Prof John Wong Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Hong Kong |
|
| 3:35 p.m. | State-of-the-art management of oral cancer and future challenges Prof Jatin P Shah Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA |
|
| 3:55 p.m. | Recent advances in colorectal cancer: where to from here? Prof John Zalcberg Department of Medical Oncology, Division of Haematology & Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia |
|
| 4:20 p.m. | TEA BREAK | |
| CLINICAL TRIALS IN ASIA | ||
Moderator Prof Steven Piantadosi Oncology Biostatistics, Johns Hopkins School of Medicine, Baltimore, MD, USA |
||
| 4:50 p.m. | Keynote Lecture 2: Opportunities for research in breast cancer in the developing world Prof Indraneel Mittra Bhopal Memorial Hospital and Research Centre, Bhopal, India |
|
| 5:20 p.m. | Workshop: Running a randomised clinical trial Chair Person: Prof Steven Piantadosi Oncology Biostatistics, Johns Hopkins School of Medicine, Baltimore, MD, USA Speakers include: Trial design, optimisation and data management Improving recruitment to randomised clinical trials in cancer Running an ethical trial Analysis; Data interpretation; Reporting
|
|
| 6:50 p.m. | END OF DAY 1 | |
| OPENING SESSION | ||
Moderator Prof Sophie Fossa Norwegian Radium Hospital, Oslo, Norway |
||
| 9:00 a.m. | Keynote Lecture 3: Cancer management and traditional medicine Prof Tony Mok Department of Clinical Oncology, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong |
|
| PREVENTION AND DIAGNOSIS II | ||
Moderator Prof Sophie Fossa Norwegian Radium Hospital, Oslo, Norway |
||
| 9:30 a.m. | Diagnosis and prevention of breast cancer by nipple aspiration fluid Prof Masakazu Toi Department of Surgery (Breast Surgery), Graduate School of Medicine, Kyoto University, Kyoto, Japan |
|
| 9:50 a.m. | Strategies for cervical cancer prevention: the right one for the right community A/Prof Eng-Hseon Tay Department of Gynaecological Subspecialties and Gynaecological Oncology Unit, KK Women’s & Children’s Hospital, Singapore |
|
| 10:10 a.m. | Strategies for the prevention of ovarian cancer Prof Maurie Markman The University of Texas MD Anderson Cancer Center, Houston, TX, USA |
|
| 10:30 a.m. | Early diagnosis of prostate cancer without unnecessary treatment in those who will not benefit Prof James Denham University of Newcastle, Newcastle, Australia |
|
| 10:50 a.m. | TEA BREAK | |
| DISEASE MANAGEMENT II | ||
Moderator Prof Maurie Markman The University of Texas MD Anderson Cancer Center, Houston, TX, USA |
||
| 11:45 a.m. | Treatment of advanced non-small-cell lung cancer with chemotherapy: An Asian experience Prof Sumitra Thongprasert Department of Medicine, Chiang Mai University, Chiang Mai, Thailand |
|
| 12:05 p.m. |
The Breast Health Global Initiatives Foundation: clinical practice guidelines for the management of breast cancer in developing countries Prof Cheng-Har Yip Department of Surgery, University of Malaya Medical Centre, Kuala Lumpur, Malaysia |
|
| 12:25 p.m . | Management of cancer in uterine cervix Prof Chyong-Huey Lai Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan |
|
| 12.45 p.m | Salvage therapy of epithelial ovarian cancer: what is the appropriate setting for the Asian situation? Dr Sarikapan Wilailak Department of Obstetrics and Gynaecology, Ramathibodi Hospital, Bangkok, Thailand |
|
| 1:05 p.m. | LUNCH AND POSTER SESSION II | |
| PALLIATIVE CARE AND QUALITY OF LIFE | ||
Moderator Prof Tony Mok Department of Clinical Oncology, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong |
||
| 2:30 p.m. | The need for oncologists and other doctors to learn about long-term effects after cancer Prof Sophie Fossa Norwegian Radium Hospital, Oslo, Norway |
|
| 2:50 p.m. | Why patient recorded quality of life data are more important parameters in trials? |
|
| 3:10 p.m. | The role of palliation and supportive care in effective cancer management Dr Nigel Sykes St Christopher Hospice, London, UK |
|
| 3:30 p.m. | Palliative care: An Asian perspective Dr Cynthia Goh Department of Palliative Medicine, National Cancer Centre Singapore, Singapore |
|
| 3:50 p.m. | The declaration of Venice: A global palliative care research initiative, with a special focus on developing countries Dr Marilẻne Filbet Palliative Care Unit, Central Hospital, University of Lyon, Lyon, France |
|
| 4:10 p.m. | TEA BREAK | |
| POSTER DISCUSSION SESSION | ||
4:40 p.m. |
Moderator Prof John Zalcberg Department of Medical Oncology, Division of Haematology and Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Australia |
|
| Effect of oral pilocarpine on treatment-related morbidity in patients receiving curative radiotherapy for head and neck cancers Dr Shikha Goyal Department of Radiotherapy and Oncology, All India Institute of Medical Sciences, New Delhi, India |
||
| New Prognostic Score to Predict Distant Metastasis in Nasopharyngeal Carcinoma Following Conformal Radiotherapy Dr Skye Cheng Department of Radiation Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan |
||
| 99mTc-Glucarate, a potential radiopharmaceutical for assessment of tumour viability: from bench to bedside Dr Partha Choudhury Department of Nuclear Medicine, Rajiv Gandhi Cancer Institute & Research Center, Delhi, India |
||
| EMERGING TECHNOLOGIES AND ECONOMIC REALITIES | ||
Moderator Prof John Zalcberg Department of Medical Oncology, Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia |
||
| 5:10 p.m. | Non-FDG-based PET/CT in oncology Prof Peter Ell Institute of Nuclear Medicine, University College London Medical School, London, UK |
|
| 5:30 p.m. | The impact of molecular biology in new anticancer drug development Prof Gilberto Schwartsmann Hospital de Clinicas de Porto, Alegre Porto Alegre, Brazil |
|
| 5:50 p.m. | Integrating emerging technologies in emerging economies: the radiotherapy scenario A/Prof Rajiv Sarin Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Cancer Centre, Mumbai, India |
|
| 6:10 p.m. | Role of computer-assisted surgery in the present and future Dr. Khurshid Ahad Guru Roswell Park Cancer Institute, New York, USA |
|
| 6:30 p.m. |
Keynote Lecture 4: Paying for modern cancer care – can we afford it? Prof Sir Michael Rawlins National Institute for Health & Clinical Excellence, London, UK |
|
| 7:00 p.m. | END OF FORUM | |
| Note: Programme subject to change. | ||
|
|
|
|
|
